Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FHKT5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,623
Award facts
- Contract value 100% obligated
- $25,622.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,622.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The award, issued on December 17, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and carries no set-aside designation, indicating the vendor won this award through unrestricted federal procurement competition. The product will be delivered to Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling and a completion date of December 31, 2036. The PPV-G GEN V represents part of DLA's broader $30.3 billion acquisition strategy to establish regional prime vendor contractors supplying comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. EXPAREL, a surgical anesthetic product, aligns with DMS Pharmaceutical Group's documented product portfolio of specialty surgical products, prescription medications, biologics, and medical consumables that support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FHKT5?
SPE2DR26FHKT5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FHKT5 worth?
The government has obligated $25,623 on SPE2DR26FHKT5.
Is contract SPE2DR26FHKT5 an order under another contract?
Yes. SPE2DR26FHKT5 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKT5 competed?
The extent of competition for SPE2DR26FHKT5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award